Sign in
4

Changes in Ownership

CRESCENT BIOPHARMA, INC. Filed Acc 0001209191-18-003392

Options or other derivatives

  • SVP Clinical Development, CMO acquired 75,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Thackray Helen M. · SVP Clinical Development, CMO

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2018-01-10 Grant or award : show line 1 in the form Employee Stock Option (right to buy) +75,000 75,000 D
Loading xslF345X03/doc4.xml…